top of page



How to become a Principal Investigator in Bosnia and Herzegovina?
We continue to share a series of guides designed to help physicians become Principal Investigators
May 21


Why do some schizophrenia trial sites succeed… while others don’t?
In one of our multi-country psychiatry studies across Hungary, Serbia, and Croatia, the starting point looked strong
May 11


Schizophrenia trials are not just about recruitment. They have real clinical and social impact.
Following our previous insights on feasibility and site performance, one important aspect is often overlooked: The broader value these studies bring — beyond the protocol. Based on our experience at Viacrystal, particularly in studies involving established or generic treatments in schizophrenia, several consistent patterns emerged across Hungary, Serbia, and Croatia. 1. Strong regulatory support Regulatory authorities in the region are generally supportive of these studie
Apr 16


What 9 Years of Schizophrenia Feasibility Work Taught Us About Trial Success
Unlike many somatic indications, schizophrenia trials involve layers of complexity that are often underestimated
Apr 16


Creativity, Meaning, and a Space That Reflects It
Celebrating 5 years in Viacrystal Budapest Headquarters
Mar 6
bottom of page
